封面
市场调查报告书
商品编码
1547519

全球放射性皮肤炎市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Radiation Dermatitis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: | 出版商: Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

全球放射性皮肤炎市场需求预计将从 2023 年的 5.0241 亿美元达到 2032 年的近 8.1693 亿美元,2024-2032 年研究期间复合年增长率为 5.55%。

放射性皮肤炎、放射性皮肤炎或X射线皮肤炎是癌症肿瘤放射治疗的外束电离辐射引起的皮肤损伤或放射性烧伤。它也可能很少由介入手术(例如栓塞手术、冠状动脉造影和留置导管置入)期间暴露于辐射引起。放射性皮肤炎主要采用外用药物治疗,如皮质类固醇、外用抗生素、亲水性乳膏、口服药物如口服皮质类固醇、口服止痛药、抗发炎药、抗生素和敷料。

市场动态

越来越多的手术,包括放射治疗、栓塞手术、冠状动脉造影和留置导管放置,导致放射性皮肤炎盛行率增加。癌症负担的不断增加以及调强放射治疗等放射治疗技术的进步正在推动全球放射性皮肤炎市场的发展。放射治疗是放射性皮肤炎发生率上升的主要原因。放射治疗仍然是癌症治疗的重要组成部分,近 50% 的癌症患者在治疗期间的某个时刻接受放射治疗。减少放射治疗相关副作用的努力预计将为预测时间内的市场扩张提供利润丰厚的机会。然而,缺乏认识以及与放射性皮肤炎治疗相关的高成本预计将限制市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具还对全球放射性皮肤炎市场的每个细分市场进行了包容性评估。放射性皮肤炎产业的成长和趋势为本研究提供了整体方法。

市场区隔

放射性皮肤炎市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料,从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

  • 口服药物(皮质类固醇、口服止痛药和抗生素)
  • 外用(皮质类固醇、亲水性乳膏、外用抗生素)
  • 敷料(水凝胶、水胶体、无刺隔离膜、蜂蜜纱布、硅酮涂层敷料等)

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局
  • 零售药局

区域分析

本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲放射性皮肤炎市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。放射性皮肤炎市场的主要参与者包括 3M 公司、MeInlycke Health Care AB、Smith & Nephew Plc、Integra Lifesciences Holdings Corporation、Intermed SA、ConvaTec Group Plc、BMG Pharma SPA 本节包括竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章:前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章:执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章:放射性皮肤炎 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按产品分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析:按地区

第 4 章:价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章:全球辐射皮肤炎市场分析:按产品

  • 概述(按产品)
  • 按产品分类的历史和预测资料分析
  • 口服药物(皮质类固醇、口服止痛药和抗生素)
  • 外用(皮质类固醇、亲水性乳膏、外用抗生素)
  • 敷料(水凝胶、水胶体、无刺隔离膜、蜂蜜纱布、硅酮涂层敷料等)

第 6 章:全球放射性皮肤炎市场分析:按分销管道

  • 配销通路概述
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局
  • 零售药局

第 7 章:全球放射性皮肤炎市场分析:依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章:放射性皮肤炎公司的竞争格局

  • 放射性皮肤炎市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章:公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • 3M Company
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • MeInlycke Health Care AB
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Smith & Nephew Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Integra Lifesciences Holdings Corporation
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Intermed SA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • ConvaTec Group Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • BMG Pharma SPA
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中,财务详细资讯和最新发展视情况而定,或对私人公司而言可能不包括在内

Product Code: VMR11215085

The global demand for Radiation Dermatitis Market is presumed to reach the market size of nearly USD 816.93 Million by 2032 from USD 502.41 Million in 2023 with a CAGR of 5.55% under the study period 2024-2032.

Radiation dermatitis, radiodermatitis, or x-ray dermatitis is skin damage or a radiation burn caused by external beam ionizing radiation of radiotherapy for cancer tumors. It may also rarely result from exposure to radiation during interventional procedures such as embolization procedures, coronary angiography, and indwelling catheter placements. Radiation dermatitis is primarily treated with topical agents such as corticosteroids, topical antibiotics, hydrophilic creams, oral medications like oral corticosteroids, oral analgesics, anti-inflammatory agents, antibiotics, and dressings.

MARKET DYNAMICS

A rising number of procedures, including radiotherapy, embolization procedures, coronary angiography, and indwelling catheter placements, are responsible for increasing radiation dermatitis prevalence. The escalating burden of cancer and advances in radiation delivery technology, such as intensity-modulated radiation therapy, is driving the global radiation dermatitis market. Radiotherapy is majorly contributing to the rising radiation dermatitis incidences. Radiation therapy remains an essential component of cancer treatment, with nearly 50% of cancer patients receiving radiation therapy at some point during their treatment. Rising effort towards reducing side effects associated with radiation therapy is expected to offer lucrative opportunities for the market expansion during the forecast timeframe. However, lack of awareness and the high cost associated with radio dermatitis treatment is anticipated to restrict the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Radiation Dermatitis. The growth and trends of Radiation Dermatitis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Radiation Dermatitis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Oral Medication (Corticosteroids, Oral analgesics & Antibiotics)
  • Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics)
  • Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others)

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Radiation Dermatitis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiation Dermatitis market include 3M Company, MeInlycke Health Care AB, Smith & Nephew Plc, Integra Lifesciences Holdings Corporation, Intermed S.A, ConvaTec Group Plc, BMG Pharma S.P.A. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. RADIATION DERMATITIS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Historic and Forecast Sales By Regions
  • 5.4. Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Historic and Forecast Sales By Regions
  • 5.5. Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Historic and Forecast Sales By Regions

6. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 6.1. Overview By Distribution Channel
  • 6.2. Historical and Forecast Data Analysis By Distribution Channel
  • 6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 6.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 6.5. Online Pharmacies Historic and Forecast Sales By Regions
  • 6.6. Retail Pharmacies Historic and Forecast Sales By Regions

7. GLOBAL RADIATION DERMATITIS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE RADIATION DERMATITIS COMPANIES

  • 8.1. Radiation Dermatitis Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF RADIATION DERMATITIS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. 3M Company
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. MeInlycke Health Care AB
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Smith & Nephew Plc
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Integra Lifesciences Holdings Corporation
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Intermed S.A
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. ConvaTec Group Plc
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. BMG Pharma S.P.A
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Market Sales By Geography (USD MN)
  • Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Market Sales By Geography (USD MN)
  • Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Radiation Dermatitis Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Radiation Dermatitis Report
  • Market Research Process
  • Market Research Methodology
  • Global Radiation Dermatitis Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Oral Medication (Corticosteroids, Oral analgesics & Antibiotics) Market Sales By Geography (USD MN)
  • Topical (Corticosteroids, Hydrophilic Creams, Topical Antibiotics) Market Sales By Geography (USD MN)
  • Dressings (Hydrogel, Hydrocolloid, No Sting Barrier Film, Honey Impregnated Gauze, Silicone Coated Dressing, Others) Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.